Nutritional status, hormonal stress and psychiatric symptoms in severely malnourished anorexia nervosa (AN) patients

International audienc

Image charge shift in high-precision Penning traps

An ion in a Penning trap induces image charges on the surfaces of the trap electrodes. These induced image charges are used to detect the ion's motional frequencies, but they also create an additional electric field, which shifts the free-space cyclotron frequency typically at a relative level of several 10 −11. In various high-precision Penning-trap experiments, systematics and their uncertainties are dominated by this so-called image charge shift (ICS). The ICS is investigated in this work by a finite-element simulation and by a dedicated measurement technique. Theoretical and experimental results are in excellent agreement. The measurement is using singly stored ions alternately measured in the same Penning trap. For the determination of the ion's magnetron frequency with relative precision of better than 10 parts per billion, a Ramsey-like technique has been developed. In addition, numerical calculations are carried out for other Penning traps and agree with older ICS measurements.peerReviewe

g Factor of Lithiumlike Silicon: New Challenge to Bound-State QED

The recently established agreement between experiment and theory for the $g$ factors of lithiumlike silicon and calcium ions manifests the most stringent test of the many-electron bound-state quantum electrodynamics (QED) effects in the presence of a magnetic field. In this Letter, we present a significant simultaneous improvement of both theoretical $g_\text{th} = 2.000\,889\,894\,4\,(34)$ and experimental $g_\text{exp} = 2.000\,889\,888\,45\,(14)$ values of the $g$ factor of lithiumlike silicon $^{28}$Si$^{11+}$. The theoretical precision now is limited by the many-electron two-loop contributions of the bound-state QED. The experimental value is accurate enough to test these contributions on a few percent level.Comment: 5 pages, 1 figur

Higher cardiogenic potential of iPSCs derived from cardiac versus skin stromal cells

Prior studies have demonstrated that founder cell type could influence induced pluripotent stem cells (iPSCs) molecular and developmental properties at early passages after establishing their pluripotent state. Herein, we evaluated the persistence of a functional memory related to the tissue of origin in iPSCs from syngeneic cardiac (CStC) vs skin stromal cells (SStCs). We found that, at passages greater than 15, iPSCs from cardiac stromal cells (C-iPSCs) produced a higher number of beating embryoid bodies than iPSCs from skin stromal cells (S-iPSCs). Flow cytometry analysis revealed that dissected beating areas from C-iPSCs exhibited more Troponin-T positive cells compared to S-iPSCs. Beating areas derived from C-iPSCs displayed higher expression of cardiac markers, more hyperpolarized diastolic potentials, larger action potential amplitude and higher contractility than beaters from skin. Also, different microRNA subsets were differentially modulated in CStCs vs SStCs during the reprogramming process, potentially accounting for the higher cardiogenic potentials of C-iPSCs vs S-iPSCs. Therefore, the present work supports the existence of a founder organ memory in iPSCs obtained from the stromal component of the origin tissue

Effects of metformin on microvascular function and exercise tolerance in women with angina and normal coronary arteries - A randomized, double-blind, placebo-controlled study

OBJECTIVES This study sought to determine whether metformin improves vascular function or myocardial ischemia in nondiabetic subjects. BACKGROUND Metformin prevents diabetes and may reduce coronary events in patients with diabetes, but effects on microvascular function and angina are not clear. METHODS We conducted an 8-week double-blind, randomized, placebo-controlled study of metformin 500 mg twice a day in 33 nondiabetic women with a prior history of normal coronary angiography but two consecutive positive (ST-segment depression >= 1 mm) exercise tolerance tests. All parameters were measured at baseline and at 8 weeks, together with an in vivo assessment of forearm (skin) microvascular function using laser Doppler imaging combined with iontophoresis. RESULTS In comparison with placebo (n = 17), metformin recipients (n = 16) showed significant reductions in weight and in homeostatic model assessment for insulin resistance (p < 0.05, intention to treat). Endothelium-dependent microvascular responses improved significantly with metformin (2-way repeated analysis of variance, p = 0.0003), but responses with placebo were unchanged (p = 0.50). A comparison of change in acetylcholine responses between metformin and placebo recipients was significant, whether analyzed by a 2-way analysis of variance (p < 0.0001) or change in area under curves (mean change +392 perfusion units, 95% confidence interval [Cl] 20 to 764). Endothelium-independent responses were not altered. Maximal ST-segment depression (-0.84 mm, 95% Cl -1.49 to -0.20, p = 0.013), Duke score (6.1 U, 95% Cl 1.8 to 10.5, p = 0.008), and chest pain incidence (-0.11 episodes/day, 95% CI -0.22 to 0.00, p = 0.056) improved in metformin relative to placebo recipients. CONCLUSIONS Metformin may improve vascular function and decrease myocardial ischemia in nondiabetic women with chest pain and angiographically normal coronary arteries. Larger controlled trials of longer duration are warranted